{"entity":{"id":"princess-maxima","kind":"institution","name":"Princess Máxima Center for Pediatric Oncology","aka":["Prinses Máxima Centrum","Máxima"],"tldr":"The national children's cancer centre of the Netherlands, which concentrates all Dutch paediatric oncology care and research on one Utrecht campus.","summary":"Opened in 2018, the Princess Máxima Center brought together paediatric oncology from the Dutch university hospitals into a single specialised hospital and research institute next to UMC Utrecht and the Wilhelmina Children's Hospital. Every child is offered whole-genome and transcriptome sequencing at diagnosis, and research groups led by figures such as Jarno Drost, Monique den Boer and Michel Zwaan develop tumour organoids, leukaemia genomics and early-phase drug trials through the ITCC European consortium. Alexander Eggermont serves as chief scientific officer. The centre treats leukaemias, brain tumours, neuroblastoma, sarcomas and renal tumours, offers CAR-T and transplantation, and runs one of Europe's largest paediatric cancer survivorship programmes.","asOf":"2026-09-09","links":[{"label":"Homepage","url":"https://www.prinsesmaximacentrum.nl/en"},{"label":"Research","url":"https://research.prinsesmaximacentrum.nl"}],"tags":[],"related":[],"cancers":["all-leukemia","aml","neuroblastoma","glioblastoma","sarcoma"],"sections":["diagnostics","cell-therapy"],"technologies":["wes-wgs","organoids","car-t","rna-seq","proton-therapy"],"targets":[],"drugs":[],"companies":["curie-nki-eortc"],"institutions":["umc-utrecht"],"pathways":[],"terms":[],"trials":[],"people":["alexander-eggermont","rene-medema"],"bottlenecks":["b-rare-cancers","b-survivorship"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Utrecht","country":"NL","lat":52.085,"lng":5.171,"institutionType":"cancer-center","website":"https://www.prinsesmaximacentrum.nl/en","university":"Utrecht University","programs":["National paediatric oncology hospital","Whole-genome sequencing for every child","Paediatric organoids","ITCC early-phase trials","Survivorship (LATER)"]},"route":"/institutions/princess-maxima/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"},{"id":"neuroblastoma","kind":"cancer","name":"Neuroblastoma (paediatric)","route":"/cancers/neuroblastoma/"},{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"}],"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"},{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"}],"technology":[{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"},{"id":"organoids","kind":"technology","name":"Patient-derived organoids","route":"/technologies/organoids/"},{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"},{"id":"rna-seq","kind":"technology","name":"RNA sequencing & expression profiling","route":"/technologies/rna-seq/"},{"id":"wes-wgs","kind":"technology","name":"Whole-exome & whole-genome sequencing","route":"/technologies/wes-wgs/"}],"company":[{"id":"curie-nki-eortc","kind":"company","name":"EORTC","route":"/companies/curie-nki-eortc/"},{"id":"itcc","kind":"company","name":"Innovative Therapies for Children with Cancer (ITCC)","route":"/companies/itcc/"}],"institution":[{"id":"umc-utrecht","kind":"institution","name":"UMC Utrecht Cancer Center","route":"/institutions/umc-utrecht/"}],"person":[{"id":"alexander-eggermont","kind":"person","name":"Alexander Eggermont","route":"/people/alexander-eggermont/"},{"id":"inge-van-der-sluis","kind":"person","name":"Inge M. van der Sluis","route":"/people/inge-van-der-sluis/"},{"id":"rene-medema","kind":"person","name":"René Medema","route":"/people/rene-medema/"},{"id":"rob-pieters","kind":"person","name":"Rob Pieters","route":"/people/rob-pieters/"}],"bottleneck":[{"id":"b-rare-cancers","kind":"bottleneck","name":"Rare and paediatric cancers without markets","route":"/bottlenecks/b-rare-cancers/"},{"id":"b-survivorship","kind":"bottleneck","name":"Survivorship and late effects are neglected","route":"/bottlenecks/b-survivorship/"}]}}